Certificate Under Regulation 40 (10) Of SEBI (Listing Regulations And Disclosure Requirements) Regulation, 2015
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a Certificate received from M/s. Mukesh Agarwal & Co., Company Secretaries, for the half-year ended on September 30, 2018. Kindly acknowledge receipt of the same. Compliance Certificate- Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - For Half Year Ended September 30, 2018
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Compliance Certificate certifying the compliance with the requirement of Regulation 7(2) for the half year ended September 30, 2018. You are requested to take the same on your record. Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 063630 Name of the Signatory :- Sumit GoelDesignation :- Company Secretary and Compliance Officer Shareholding for the Period Ended September 30, 2018
Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Outcome of Board Meeting
We wish to inform you that the Board of Directors of the Company at its meeting held today, have, inter alia, considered the following: 1. Took note of the resignation of Mr. Rahul Ranjan as Company Secretary with immediate effect due to personal reasons; 2. Approved the appointment of Mr. Sumit Goel as Company Secretary (Interim) with immediate effect; and 3. Approved the appointment of Mr. Girish Gupta as Chief Financial Officer (Interim) with immediate effect. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the captioned subject, please find enclosed the voting results of the Annual General Meeting held on September 28, 2018 in the prescribed format along with Scrutinizer's report as 'Annexure 1'. Shareholder Meeting / Postal Ballot-Outcome of AGM
It is hereby informed that Fortis Healthcare Limited ('the Company') held its 22nd Annual General Meeting ('AGM') on September 28, 2018 at 12:30 PM at the National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali, Punjab - 160062. With reference to the above, please find enclosed the following: 1. Proceedings of the AGM in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; and...
Competition watchdog may give nodto Fortis-IHH deal by October-end
The Fortis Healthcare board had in July unanimously accepted the binding offer from IHH Healthcare Berhad to invest 4,000 crore in the cash-strapped hospital chain Submission Of Postal Ballot Notice & Form As Prescribed Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the captioned subject, please find enclosed the postal ballot Notice and Form.